较小直径的覆膜经颈静脉肝内门体分流术支架与生存率提高相关
该研究基于德国多中心TIPS注册数据,纳入185例接受覆膜镍钛合金支架的患者,比较8 mm支架与10 mm支架(含或不含8 mm球囊欠扩张)对生存的影响。倾向性评分分析显示,8 mm支架组生存时间显著长于10 mm支架组,且1年及5年死亡率与10 mm支架全扩张及基线肌酐水平相关。
要点
- 8 mm支架组生存时间显著长于10 mm支架组,无论10 mm支架是否欠扩张。
- 10 mm支架欠扩张者术后1个月生存比例显著高于未欠扩张者,但3个月时无显著差异。
- 1年死亡率与支架全扩张至10 mm及基线肌酐浓度相关,5年死亡率与10 mm支架及基线肌酐相关。
核心结论
- 较小支架(名义直径8 mm,而非10 mm支架欠扩张)与10 mm支架相比,与生存期延长相关,且独立于肝脏特异性预后标准。
研究设计与样本
- 研究使用德国TIPS在线多中心注册数据,收集2006年2月至2010年9月期间185例接受覆膜镍钛合金支架的患者(中位年龄55岁,女性占30%)。
- 107例因难治性腹水接受TIPS,78例因静脉曲张出血接受TIPS;有肝性脑病风险(高龄、既往发作)或肝衰竭风险(胆红素>3 mg/dL)者及TIPS时行静脉曲张栓塞的出血患者接受8 mm支架(n=53),其余接受10 mm支架(n=132)。
主要发现
- 8 mm支架组生存时间为34±26个月,显著长于10 mm支架组的18±19个月,无论10 mm支架是否完全扩张或欠扩张。
- 10 mm支架欠扩张组术后1个月生存比例为95%,高于未欠扩张组的84%(P=0.03);3个月生存差异无统计学意义(P=0.10)。
- 多因素分析中,1年死亡率与支架完全扩张至10 mm相关(HR 2.0;95%CI 1.1-3.5),并与基线血清肌酐浓度相关(HR 1.5;95%CI 1.0-1.7)。
- 5年死亡率与使用10 mm支架相关(HR 1.8;95%CI 1.4-2.7),并与基线肌酐浓度相关(HR 1.3;95%CI 1.1-1.6)。
临床怎么用
- 作者结论认为,较小支架(名义直径8 mm)与10 mm支架相比与生存期延长相关,独立于肝脏特异性预后标准。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: We studied the effects of diameter of covered, self-expandable, nitinol stents on survival times of patients with a transjugular intrahepatic portosystemic shunt (TIPS). METHODS: We collected data from 185 patients (median age, 55 y; 30% female) who received a covered nitinol stent, from February 2006 through September 2010, using the online multicenter German TIPS registry. TIPS were given to 107 patients for refractory ascites and to 78 patients for variceal bleeding. Patients at risk of hepatic encephalopathy (owing to advanced age, prior episodes) or liver failure (bilirubin level, >3 mg/dL), and bleeding patients receiving variceal embolization at TIPS, received 8-mm stents (n = 53). The remaining patients received 10-mm stents (n = 132). Eighty-one of the 10-mm stents were underdilated using 8-mm dilation balloons. Clinical and biochemical data were collected after TIPS placement at 1 month, 3 months, 6 months, 9 months, 1 year, and thereafter every 3 to 6 months. Groups were compared using propensity score analysis. RESULTS: Patients who received 8-mm stents survived significantly longer (34 ± 26 mo) than patients who received 10-mm stents (18 ± 19 mo), regardless of whether they were fully dilated or underdilated. When we compared 10-mm stents with or without underdilation, we found that a significantly higher proportion of patients who received underdilated stents survived for 1 month after TIPS placement (95% vs 84%; P = .03), but not for 3 months (P = .10). In multivariate analysis, 1-year mortality correlated with full dilation of the stent to 10 mm (hazard ratio [HR], 2.0; 95% CI, 1.1-3.5) and with serum creatinine concentration at baseline (HR, 1.5; 95% CI, 1.0-1.7). Five-year mortality was associated with use of the 10-mm stents (HR, 1.8; 95% CI, 1.4-2.7) and baseline concentration of creatinine (HR, 1.3; 95% CI, 1.1-1.6). CONCLUSIONS: A smaller stent (nominal diameter of 8 mm, but not underdilation of a 10-mm stent) is associated with a prolonged survival compared with 10-mm stents, independent of liver-specific prognostic criteria.
引用
- Trebicka J, Bastgen D, Byrtus J, et al. Smaller-Diameter Covered Transjugular Intrahepatic Portosystemic Shunt Stents Are Associated With Increased Survival. Clin Gastroenterol Hepatol. 2019. PMID: 30940552. doi:10.1016/j.cgh.2019.03.042
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。